HEADER IMMUNE SYSTEM 23-AUG-99 1CV9 TITLE NMR STUDY OF ITAM PEPTIDE SUBSTRATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG-ALPHA ITAM PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 178-189; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: SEQUENCE FROM HUMAN IG-ALPHA ITAM KEYWDS LYN TYROSINE KINASE, ITAM, IMMUNORECEPTOR TYROSINE ACTIVATION MOTIF, KEYWDS 2 PEPTIDE SUBSTATE, IMMUNE SYSTEM EXPDTA SOLUTION NMR AUTHOR B.S.GAUL,M.L.HARRISON,R.L.GEAHLEN,C.B.POST REVDAT 7 16-OCT-24 1CV9 1 REMARK REVDAT 6 16-FEB-22 1CV9 1 REMARK LINK REVDAT 5 24-FEB-09 1CV9 1 VERSN REVDAT 4 01-APR-03 1CV9 1 JRNL REVDAT 3 31-MAY-00 1CV9 3 JRNL ATOM SEQRES REVDAT 2 05-NOV-99 1CV9 3 ATOM SEQRES REVDAT 1 31-AUG-99 1CV9 0 JRNL AUTH B.S.GAUL,M.L.HARRISON,R.L.GEAHLEN,R.A.BURTON,C.B.POST JRNL TITL SUBSTRATE RECOGNITION BY THE LYN PROTEIN-TYROSINE KINASE. JRNL TITL 2 NMR STRUCTURE OF THE IMMUNORECEPTOR TYROSINE-BASED JRNL TITL 3 ACTIVATION MOTIF SIGNALING REGION OF THE B CELL ANTIGEN JRNL TITL 4 RECEPTOR. JRNL REF J.BIOL.CHEM. V. 275 16174 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10748115 JRNL DOI 10.1074/JBC.M909044199 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1, CHARMM 23.2 REMARK 3 AUTHORS : BRUNGER, A.T. (X-PLOR), BROOKS, B.R. ET AL. REMARK 3 (CHARMM) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CV9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY NDB. REMARK 100 THE DEPOSITION ID IS D_1000009563. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 278 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM ITP WITH 0.2 MM KLYN, PH REMARK 210 7.0 PHOSPHATE BUFFER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; 2D ROESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : THE SIMULATED ANNEALING PROTOCOL REMARK 210 IN THE X-PLOR 3.1 MANUAL WAS REMARK 210 USED FOR STRUCTURE CALCULATION. REMARK 210 RESTRAINED POWELL MINIMIZATION REMARK 210 INCOPORATED THE CHARMM FORCE REMARK 210 FIELD USING THE TOP_ALL22 AND REMARK 210 PAR_ALL22 FILES IN THE X-PLOR REMARK 210 3.1 LIBRARY. 107 NOE DERIVED REMARK 210 DISTANCE RESTRAINTS WERE USED REMARK 210 THROUGH OUT THE STRUCTURE REMARK 210 CALCULATION REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH FAVORABLE NON REMARK 210 -BOND ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 3 -77.53 -90.35 REMARK 500 LEU A 4 -13.58 47.22 REMARK 500 GLU A 6 -158.76 -133.81 REMARK 500 LEU A 8 33.42 -87.67 REMARK 500 ASN A 9 94.01 73.47 REMARK 500 LEU A 10 -129.17 -104.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 6 GLY A 7 -144.37 REMARK 500 GLY A 7 LEU A 8 -110.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 13 DBREF 1CV9 A 0 13 PDB 1CV9 1CV9 0 13 SEQRES 1 A 14 ACE ASP GLU ASN LEU TYR GLU GLY LEU ASN LEU ASP ASP SEQRES 2 A 14 NH2 HET ACE A 0 6 HET NH2 A 13 3 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 H2 N LINK C ACE A 0 N ASP A 1 1555 1555 1.34 LINK C ASP A 12 N NH2 A 13 1555 1555 1.35 SITE 1 AC2 1 ASP A 12 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 HETATM 1 C ACE A 0 -0.267 -2.790 -0.501 1.00 0.00 C HETATM 2 O ACE A 0 -1.362 -2.623 0.028 1.00 0.00 O HETATM 3 CH3 ACE A 0 -0.119 -3.694 -1.659 1.00 0.00 C HETATM 4 H1 ACE A 0 0.496 -3.204 -2.441 1.00 0.00 H HETATM 5 H2 ACE A 0 -1.122 -3.940 -2.065 1.00 0.00 H HETATM 6 H3 ACE A 0 0.387 -4.626 -1.324 1.00 0.00 H